Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 8 of 8 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company AskBio | Activity: Research and Development | Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. | Location Research Triangle Park |
| |
Company Bavarian Nordic Inc. | Activity: Research and Development | Company Description Bavarian Nordic develops, manufactures and commercializes vaccines for infectious diseases. | Location Durham |
| |
Company BioCryst Pharmaceuticals Inc. | Activity: Research and Development | Company Description BioCryst Pharmaceuticals designs and develops novel, small-molecule oral drugs that block key enzymes to treat rare diseases. The Durham location houses BioCryst's clinical, regulatory and executive teams. | Location Durham |
| |
Company Chiesi USA Inc. | Activity: Research and Development | Company Description Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A, develops and commercializes products in the therapeutic areas of rare disease, respiratory, cardiovascular, neonatology and cystic fibrosis. | Location Cary |
| |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham |
| |
Company Precision BioSciences Inc. (Durham) | Activity: Research and Development | Company Description Precision BioSciences is a clinical stage in vivo gene editing company using its novel ARCUS genome editing platform to develop new treatment options for genetic and infectious diseases. | Location Durham |
| |
Company Roivant Sciences Inc. | Activity: Research and Development | Company Description Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease. | Location Durham |
| |
Company TARGAN Inc. | Activity: Research and Development | Company Description TARGAN is developing automated bio-system solutions for detecting, targeting, and delivering vaccines for the animal health industry. TARGAN's technologies aim to reduce the need for antibiotics by improving vaccination delivery. | Location Raleigh |